Castle Biosciences Inc. (CSTL) Reports Q4 EPS of $0.11

Castle Biosciences Inc. (NASDAQ: CSTL) reported Q4 EPS of $0.11, versus $0.38 reported last year. Revenue for the quarter came in at $17.6 million, versus $11.44 million reported last year.

2020 Revenue Guidance:

Castle Biosciences anticipates generating $61-64 million in revenue in 2020.

For earnings history and earnings-related data on Castle Biosciences Inc. (CSTL) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
• Is the global equity rally broadening? UBS weighs in